Monthly Archives: June 2023

FDA Approves BriaCell’s Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer
June 27, 2023

PHILADELPHIA and VANCOUVER, British Columbia, June 27, 2023 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

Skip to content